Background: Businesses increasingly conduct operations in remote areas where medical evacuation [Medevac(s)] carries more risk. Royal Dutch Shell developed a remote healthcare strategy whereby enhanced remote healthcare is made available to the patient through use of telemedicine and telemetry. To evaluate that strategy, a review of Medevacs of Shell International employees [i.e. expatriate employees (EEs) and frequent business travellers (FBTs)] was undertaken. Method: A retrospective review of Medevac data (period 2008-12) that were similar in operational constraints and population profile was conducted. Employee records and Human Resource data were used as a denominator for the population. Analogous Medevac data from specific locations were used to compare patterns of diagnoses. Results: A total of 130 Medevacs were conducted during the study period, resulting in a Medevac rate of 4 per 1000 of population with 16 per 1000 for females and 3 per 1000 for males, respectively. The youngest and oldest agegroups required Medevacs in larger proportions. The evacuation rates were highest for countries classified as 'high' or 'extreme risk'. The most frequent diagnostic categories for Medevac were: trauma, digestive, musculoskeletal, cardiac and neurological. In 9% of the total, a strong to moderate link could be made between the pre-existing medical condition and diagnosis leading to Medevac. Conclusion: This study uniquely provides a benchmark Medevac rate (4 per 1000) for EEs and FBTs and demonstrates that Medevac rates are highest from countries identified as 'high risk'; there is an age and gender bias, and pre-existing medical conditions are of notable relevance. It confirms a change in the trend from injury to illness as a reason for Medevac in the oil and gas industry and demonstrates that diagnoses of a digestive and traumatic nature are the most frequent. A holistic approach to health (as opposed to a predominant focus on fitness to work), more attention to female travellers, and the application of modern technology and communication will reduce the need for Medevacs.
Introduction
The operational requirements of many companies, including large global oil and gas companies, are such that considerable numbers of employees are assigned to business units in different parts of the world on expatriate contracts of varying durations. 1, 2 In addition, a number of employees are sent to such operating locations on work assignments periodically, and are classified as frequent business travellers (FBTs). The degree to which the medical needs of this population of expatriates (including FBTs) are met varies according to the: quality of local healthcare infrastructure; risk of (infectious) diseases and trauma, and severity of any pre-existing medical conditions. [3] [4] [5] Unfortunately, these operating locations present a multitude of health challenges to the employees who work in them. Despite the existence of preventative programs like fitness to work (FTW), transfer and travel health advice (including vaccination recommendations and prophylactic medication), acute medical issues can arise whereby access and/or quality of local available medical resources are insufficient to address issue(s) at hand. 6, 7 If medical resources cannot be obtained on-site, medical evacuation to either the nearest competent facility or back to the country of origin (i.e. repatriation) are the only options available to ensure that the medical needs of the employees are met effectively. [8] [9] [10] Special interest for this topic is derived from the fact that the demographics of the EE population are changing. Current global trends of greater longevity combined with chronic illnesses and obesity mean that a higher proportion of the EE population have pre-existing medical conditions, which may contribute to the risk of illness while on foreign assignments. [11] [12] [13] Indeed, many have commented on the increasing prominence of illness over injury in the offshore oil and gas sector. 8, [25] [26] [27] Reasons for this change in pattern of medical emergencies over time have included: increased age; improved safety management, and a move away from construction and exploration towards maintenance and operations. 1, 8, 9, 14 Thus, there is a growing need for greater sensitivity and anticipation in managing chronic illnesses along with the appropriate medical responses. 8, [14] [15] [16] Relatedly, the value of FTW assessments is being constantly scrutinized and questioned from a medical perspective as well as a business perspective.
7,17
For example, Greuters et al., 25 in their study of Dutch travellers and 'pensionados' (Dutch pensioners that live outside the Netherlands) who chose to live abroad, concluded that repatriation of some of these patients '. . .might be avoided by secure pretravel risk assessment or improvement of medical services abroad'. The issue of medical evacuation is growing in prominence for large oil and gas companies, governments and military alike. Various interests are leading to operational activities increasingly being conducted in (extremely) remote areas of the world (e.g. the Arctic and the Indian Ocean). Consequently, medical evacuation is more costly, involves more risk for both patient and others, takes longer and can have a relatively higher impact on business operations. 7, 9, 18 For these reasons, Royal Dutch
Shell has developed a remote healthcare strategy whereby the (virtual) hospital is brought to the patient rather than vice versa with the use of modern technology and communication. In this retrospective statistical review, we explored the epidemiological characteristics of 130 international medical evacuations and repatriations of expatriate employees (EEs) and FBTs undertaken by a global medical provider on behalf of Shell International between 2008 and 2012. In this study, the term 'Medevac' was defined as the 'evacuation of a sick or injured person from a remote environment to a place of safety for provision of appropriate medical attention', which included both 'routine Medevac' (e.g. via the operating company helicopter service), 'emergency Medevac' [i.e. via search and rescue (SAR) helicopter or boat] and 'repatriation' (e.g. evacuation back to base country). The aim of this study was to derive the necessary evidence to inform the development of a revolutionary 'hospital lite' and 'treat on board' remote offshore healthcare strategy by enhancing knowledge about the distribution, incidence, causes, implications and potential preventative measures associated with Medevacs within the target population. Preventative measures comprise all health activities involved in the prevention of injury and illness in remote locations. These include: fitness to work screening; health risk assessment; medical emergency response; food and water safety management, and health promotion.
Methods
The sample upon which this retrospective analysis was based derives from an anonymous historical database of 130 Shell employees (comprising both FBTs and EEs) who underwent Medevac by a global medical provider on behalf of Shell International between 2008, Q1 and 2012, Q2. FBTs were defined as those who travel: within the region (e.g. Europe) on flights of more than 4-h duration three or more times per month; on long distance intercontinental trips three or more times annually, or for one or more planned trips per year to high-risk destinations. EEs were defined as employees working outside of their base country on a long term (usually 4-years) or short term (6-months or longer) international assignment.
Countries classified as 'high-risk' were defined as having significantly higher risk of infectious disease and limited access to quality health infrastructure. Using content from public data sources and first-hand in-company knowledge, country risk ratings were determined following a review of health factors including: endemic diseases; environmental risks; road and security conditions, and the quality and availability of health care within country.
The study focused on prediction, prevention and risk of Medevacs. For the prediction of Medevacs we explored whether there were: (i) certain demographic groups at higher risk of Medevacs; (ii) any pre-existing medical conditions associated with a higher risk of Medevac, and (iii) any correlation between country-risk rating and the risk of Medevac. In addition, we identified the most frequent diagnostic categories for Medevac. For the risk of Medevacs, we investigated whether current FTW-assessment was adequate in identifying higher risk groups. Lastly, for the prevention of Medevacs, we looked at specific interventions that could be undertaken to reduce Medevac risk.
The data for this study included: basic demographic information (i.e. gender, age and nationality); the incident country and corresponding country risk categorization, and ICD-10 description and codes for the medical diagnoses for Medevac. Further detail was added to this with regard to any medical histories of employees available through employee records held by Human Resources (HR). Forty-five cases (35%) had a medical history record. The reference population consisted of 31 860 FBTs and EEs who were present in the incident countries at the time of the Medevac. While EE totals for each country were available to the same granularity as the Medevac data (by gender and age-group for each quarterly time point), numbers of FBTs were only available as yearly counts for each country. These counts were then apportioned to gender, age-group and year-quarter in the same proportions as the EE population in order to arrive at an approximate number of FBTs for the level of detail required. The total numbers of EEs and the estimated numbers of FBTs for each country, year-quarter, gender and age-group were then used to calculate Medevac rates, respectively.
Complementary analogous Medevac data were also available from operations in Aberdeen (UK), Sakhalin (Russia) and Malaysia for 99, 231 and 130 individuals, respectively. However, the primary use of these data sets was to compare the pattern of diagnoses leading to Medevac with the sample of 130 international Medevac cases given the absence of sociodemographic information and relevant population numbers.
All employees whose data were included in this study will have undergone one or more of the following FTW medicals: a transfer medical for EEs and their family prior to international assignment; an offshore medical for employees working offshore, and a remote location medical for expatriates working in a location where Medevac cannot be guaranteed to be achieved within 4-h. Typically, these medicals include a: face-to-face consultation with a medical professional, a full patient medical history, body mass index (BMI), pulse and blood pressure, lipid profile, and cardiovascular screening (for those above 40 years).
In addition, such medicals may also include: urine analysis, lung function test, and an audiogram as indicated, or required, according to the UK Oil and Gas (OGUK) FTW standard. FBTs are required to complete an online health questionnaire and training. Based on answers to these questions, the employee will either be instructed to make an appointment for follow-up with a health professional or receive a system generated message declaring that the FBT is fit for travel.
Ethical Approval
Because the retrospective analysis was undertaken by an independent academic team based in the Faculty of Health and Social Care of the Robert Gordon University (Aberdeen, Scotland), ethical approval was obtained for the study from the Robert Gordon University Research Ethics Sub-Committee. In accordance with the Research Ethics and Governance Policy of the university, that approval was contingent on the adherence of the following procedures. First, Shell International (as the gatekeeper for the historical data to be used in the retrospective statistical analysis) e-mailed all eligible individuals whose data were held in their IT system and by HR to inform them of the purpose of the review. Second, consent was obtained by means of an opt-out method in order to enhance compliance rates and expedite the analysis. Any individuals who elected not to give permission for their data to be included in the retrospective statistical analysis were removed by Shell International from the linked data set prior to providing the independent academic team with an encrypted Excel file containing the linked data with all individually identifiable variables removed and all findings reported on the basis of aggregated data. Third, all data were coded, stored and analysed under conditions of the UK.
Data Protection Act (1998) by means of an encrypted database on a secure server.
Statistical Analyses
All data manipulations and analyses were performed through IBM SPSS (versions 20 and 21). The original data (both Medevac data and denominator data) were supplied by Shell International in the form of EXCEL worksheets. These were then imported into SPSS for collation of the denominator data with the Medevac data.
Results
After excluding all family members (n ¼ 52) and employees who did not consent to inclusion of their medical data (n ¼ 1), including any fatalities (n ¼ 2), 130 cases remained from the original data set containing 185 Medevacs (70.3%) during the period 2008 (Q1) and 2012 (Q12). In order to establish the business relevance of this number of Medevac cases, a Medevac rate of 4 per 1000 was computed based on the total number of expatriate Shell International employees (N ¼ 31 860) for the study period.
Medevac Demographic Profile
Of the 130 Shell employees who required Medevacs, 42 were females (32%) and 88 were males (68%). This compared with 2669 (8%) females and 29 191 (92%) males within the total number of expatriate Shell International employees (including FBTs) for the same period. This results in a higher Medevac rate of nearly 16 per 1000 for females, compared with 3 per 1000 for males (see Table 1 ).
The majority of employees who required Medevacs during the study period (over three-quarters) were between 40 and 59 years of age, and the mean age of the evacuees was 47 years. Two of the employees (2%) were 20-29 years old, 18 (14%) were 30-39 years old, 50 (38%) were 40-49 years old, 52 (40%) were 50-59 years old and 8 (6%) were 60-75 years old. This compared with the following numbers and proportions within each age-group for the expatriate population: 20-29 years: 65 (0.20%), 30-39 years: 1688 (5.3%), 40-49 years: 13 787 (43.27%), 50-59 years: 16 270 (51.07%) and 60-75 years: 50 (0.16%). Normalizing the numbers of evacuations within each age-group by their respective expatriate populations would yield Medevac rates per 1000 shown in Table 1 . The youngest and oldest age-groups required Medevacs in proportions greater than their respective populations (see Table 1 ).
Of the 130 Medevacs that were performed during the study period, 2 (2%) were in America, 1 (1%) was in Oceania, 76 (58%) were in Europe, 39 (30%) were in Asia and 12 (9%) were in Africa. This compared with the following numbers and proportions within each continent for the expatriate population: America: 951 (3%), Oceania: 336 (1.1%), Europe: 20 604 (65.7%), Asia: 8854 (27.8%) and Africa: 1116 (3.5%). Table 1 shows the Medevac rates per 1000 of expatriate population. When the actual number of Medevacs within each continent is normalized by its respective expatriate population (including FBT's) and expressed as a rate per thousand, Africa had the highest evacuation rate (10.8 per 1000)-almost three times the overall rate of just over 4 per 1000 (see Table 1 ).
The countries from which Medevacs were undertaken are listed in Table 2 , along with country risk categories based upon the risk of infectious disease, the quality of the health infrastructure, and in-country experience. Table 5 shows the country risk category distribution of the 130 Medevacs compared with that of the total number of expatriates employed by Shell International for the same period. Normalizing the numbers of EE and FBT evacuations within each country risk-group by their respective denominator populations resulted in Medevac rates per 1000 shown in Table 3 . Not surprisingly, the evacuation rates, when broken down by country risk, were the highest for countries classified as 'high' or 'extreme' risk. The relative risk of Medevac for 'high' and 'extreme' risk countries when compared with 'low' and 'medium' risk countries was approximately 3.1. Table 4 presents the outcome of that allocation with the absolute numbers and percentage of cases for each diagnostic category.
Medevac Diagnostic Group Comparison
The top five Medevac diagnostic groups pertaining to the international offshore Medevac data (N ¼ 130) were ranked in descending order as follows: trauma, digestive, musculoskeletal, cardiac, and neurological (see Table 5 ).
Overall, the five most frequent diagnostic groups for Medevac across these four sources of data were ranked in descending order as follows: digestive, trauma, musculoskeletal, cardiac and urological (see Table 5 ).
Pre-Existing Medical Conditions and Medevacs
A pertinent question for this study was whether pre-existing medical conditions were the direct causes of Medevac. Of the 130 Medevac cases, 45 (35%) had a pre-existing medical condition recorded in their medical records. There were 12 cases (9% of the total) where a moderate to strong link could be made between the pre-existing condition and diagnosis leading to Medevac. Eight cases had a strong link between a preexisting condition and Medevac (e.g. history of arrhythmia leading to Medevac for cardiac event), and four cases had a moderate link (e.g. history of hypertension, high cholesterol and smoking leading to cardiac condition for which Medevac was necessary). For the other 33 remaining cases where a medical history had been recorded there did not appear to be a connection between pre-existing condition and reason for Medevac.
Discussion

Principal Findings
In our study, we retrospectively evaluated the medical records of patients who underwent Medevac between 2008 and 2012. Employee records and HR data were used to supply a denominator for the population. Comparative Medevac data from specific locations were used to compare patterns of diagnoses.
There were five main findings. First, female business travellers were at higher risk of Medevac than male business travellers. Second, there was evidence of an age bias. Third, Medevac rates were highest for Africa and countries classified as 'highrisk'. Fourth, the diagnoses of a digestive and traumatic nature were most frequently associated with Medevac. Fifth, illness was a more prevalent cause of Medevac than traumatic injury. The implication of each of these findings within the context of the literature is provided below. 
Gender
Nowadays, there are more female travellers than ever before. Because of the biological differences between men and women, female travellers face different obstacles when travelling abroad than male travellers. 19 Unfortunately, little attention has been paid to gender differences in the field of travel. 20 Where gender differences have been considered in previous studies, the focus has been on the effects of diseases relating to fertility, and pregnancy outcomes. 21 Our findings demonstrated that Medevac rates were higher for women than for men; a finding endorsed by other studies. For example, a United Healthcare Global poll, showed that female travellers were more likely to experience medical problems abroad. 22 In addition, Schlagenhauf and others reported that female travellers were at higher risk of developing a wide range of diseases, such as acute diarrhoea, chronic diarrhoea, irritable bowel syndrome, urinary tract infection, oral and dental conditions, and psychological stressors. 20 Our study highlights the importance of attending to the health and wellbeing needs of female travellers.
Age
The mean age of the 130 cases of Medevacs in our study was 47 years with a greater proportion of Medevacs occurring in the older age-group in comparison with the younger age-group. However, previous research has shown that younger workers have more Medevacs due to injury whilst older workers have more Medevacs due to illness. [23] [24] [25] In addition, nowadays illness has replaced injury as the major cause of Medevacs, which may explain why older patients are at higher risk of Medevac. 8, 9 Consequently, this finding lends credence to the relevance of having a fit for purpose pre-screening in place for travellers with a pre-existing medical condition.
Incident Country Risk
Our data shows that Medevac rates are highest from countries identified as 'high' or 'extreme'-risk. In addition, high-risk countries showed a greater risk of Medevacs than extreme-risk countries. This may be explained by the fact that, for extremerisk countries, the most stringent health and safety controls were put in place to manage the risk, and the company provided most of the local health infrastructure. Despite the potential importance of this factor in identifying Medevac risk, the literature regarding incident country risks in relation to Medevacs is limited. Table 4 . Comparison of top five medevac diagnostic groups across four sources of data (95% confidence intervals are given in square parentheses) 
Diagnostic Categories
Diagnoses of either a traumatic, digestive, musculoskeletal, cardiac or neurological nature were the most frequent amongst our study population. This outcome has been reported by other studies. 9, [24] [25] [26] In previous studies, 15 however, the majority of Medevacs were due to illnesses associated with the digestive system and dental problems. On the contrary, our data have shown that, over time, Medevacs for dental problems have become less prevalent whereas Medevacs for illnesses, including cardiac and neurological conditions, have increased. 9 We also found that the diagnosis of trauma, cardiovascular and neurology were most frequently reported; a finding that mirrors that of other studies.
Pre-Existing Medical Conditions
A pertinent question for this study was whether pre-existing medical conditions were the direct cause of Medevac. We found that only 9% of cases who underwent Medevac due to acute complications of a pre-existing condition. Although the literature regarding the relationship between pre-existing conditions and Medevacs is limited, the publication by Greuters et al. 25 reported a different outcome such that 82% of cases experienced Medevac due to acute complications of a pre-existing medical condition. There are two possible explanations for this difference in our findings and that of Greuters et al. 25 Firstly, the study populations differed significantly in their demographic profile. The Greuters et al. 25 sample comprised travellers and pensioners whereas our sample was based on a working population of FBTs and EEs. Secondly, our study population underwent FTW screening and had access to health and wellness programmes. In 2009, Shell Health introduced a global riskbased approach to medical screening in order to eliminate nonevidence based and non-predictive medical testing. This resulted in a reduction of protocols and testing due to recognizing the limitations and absence of evidence for FTW. Employees with pre-existing illness undergo a more tailored screening in comparison to employees with no medical history or complaints, for which guidelines are based on those of the Oil and Gas UK (OGUK) FTW recommendations. The findings from our study endorse the limitations of FTW. In addition to assessing the risk for travellers with pre-existing medical conditions, there is an urgent need to focus on overall health and human performance.
Illness over Injury
In our study, 26 (20%) of the Medevacs were from injury and 104 (80%) were from illnesses. This finding confirms the trend over time from injury to illness as a reason for Medevac in the oil and gas industry as highlighted by Ponsonby et al., 8 as well as travellers in general. [25] [26] [27] In the early years, there were substantially more cases with injuries than illnesses. 15 From 1980 onwards, cases of illness increased and those of injury decreased. 9, 14 (Thus, in terms of preventing Medevac, there is a growing need for greater sensitivity and anticipation in managing chronic illnesses along with the appropriate medical responses needed). Possible reasons for the change in the pattern of medical emergencies over time have been attributed to a variety of factors including increasing age profile of the workforce and increased safety management. In addition, a move away from construction and exploration towards maintenance and operations has also been proffered as a reason for this change. As such, they may not be generalizable to other Medevacs involving employees of other oil and gas companies. Identifying the direction of any bias introduced from exclusion by virtue of the non-consent of use of medical records in our study is not possible, but as this only pertained to one individual, it is unlikely to have a significant effect on the results reported here. Whilst this study represents one of the first of its kind in terms of seeking to obtain comparative data on initial diagnosis and final diagnosis, gathering this information proved more challenging than anticipated. Analysis of the accuracy of diagnosis and patterns of diagnosis per risk category could not be addressed.
One of the main strengths of this study, however, has been the use of routinely collected data on Medevacs, rather than selfreported data, which can result in recall bias. However, the authors acknowledge that the findings regarding the association between country-risk rating and the risk of Medevac may reflect the fact that high risk countries are more likely to require Medevacs by virtue of restrictions on accessibility to healthcare. Finally, the findings rely on small numbers and must therefore be treated with caution.
Conclusions
This study uniquely provides a benchmark Medevac rate (4 per 1000) for EEs and FBTs and demonstrates that: Medevac rates are highest from Africa and countries identified as 'high risk'; there is an age and gender bias. Consequently, there is potential benefit to be derived from tailored gender-specific travel health advice. In addition, pre-existing medical conditions are of notable relevance. It demonstrates that diagnoses of a digestive and traumatic nature are the most frequent. The current understanding that the primary emphasis for Medevac has shifted from injury to illness has also been confirmed in this study. This is likely attributable to improvements in the development of adherence to safety standards worldwide and the changing demographics of our population (e.g. ageing). While the need for FTW evaluations remains, FTW exams on healthy individuals are known to have limited predictive value for future development of medical problems. 29 Strategic focus on creating a culture where people care about health and the health of others, will make way for a focus beyond health alone to human performance through innovative health promotion programs. This will include an increased focus on sustainable employability and mental health and resilience. The identification of the top five diagnostic categories will allow for further improvements to our RHC strategy in terms of defining competency of RHC practitioners, equipment, supplies and telemedicine capabilities. The requirements for such improvements are evident in the publication of the recent consensus document on Competency and Training for Health Practitioners Working in Remote Oil and Gas Operations.
7 While Medevacs will remain inevitable, future innovative strategies like RHC have been designed to improve healthcare (quicker and more accurate diagnostics and treatment). The high cost of managing chronic illnesses in remote locations has made workplace health promotion programmes (WHPP) very attractive. Anecdotal evidence from energy operators piloting WHPP at remote locations suggests significant reduction in cardiovascular risk, and the optimization of several health parameters including body mass index (BMI) and incidence of smoking. Participation rates have also been high due to the captive population in remote locations. In turn this has resulted in lower medical costs (including those related to evacuations), as well as increased productivity, lower absenteeism, lower turnover and increased morale. 7 Health promotion programmes such as 'Be Well' and 'Think Well' (Shell Health's Wellness and Resilience programmes) demonstrate a culture of care. Evidence suggests that sites where a culture of care is firmly embedded deliver significantly better, more sustainable health and safety outcomes compared to others. 28 Telemedicine is a tool that enhances remote healthcare as a means of bringing the hospital to the patient (rather than vice versa). In addition to facilitating diagnosis and treatment, telemedicine connection to competent topside (real-time medical advice provided by medical professionals via telecommunications) has been shown to reduce delays in Medevac (e.g. through faster diagnosis) and prevent unnecessary Medevacs (e.g. through accurate specialist assessments). 7 Telemedicine has also been successful in facilitating continuous medical education to remote healthcare practitioners, supporting preventive programs, and monitoring employee's health in remote locations. However, it is important to empirically evaluate the effective use and outcome of future evacuation and preventative strategies such as telemedicine as a robust evidence-base to justify and, thereby, facilitate commonplace implementation in remote occupational environments. Data from a large prospective 2-year study on the benefits of remote healthcare (including the use of telemedicine) is currently underway on multiple oil and gas platforms. The aim is to ascertain effectiveness in terms of patient outcome and economic benefit.
